Development of Second-Generation CDK2 Inhibitors for the Prevention of Cisplatin-Induced Hearing Loss

Overview of attention for article published in Journal of Medicinal Chemistry, August 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 1 X user

patent: 15 patents

Readers on

mendeley: 38 Mendeley

So far, Altmetric has seen 15 patents that reference this research output.

Pyrazolopyridine inhibitors of c-Jun-n-Terminal kinases and uses thereof

Grant US-12637453-B2

United States of America

26 May 2026

Inhibitors of cyclin-dependent kinases

Grant US-RE50776-E1

United States of America

03 Feb 2026

Methods and compositions for the prevention and treatment of hearing loss

Grant US-12427149-B2

United States of America

30 Sep 2025

Inhibitors of cyclin-dependent kinase 7 and uses thereof

Grant US-12281126-B2

United States of America

22 Apr 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 11 additional patents.